A Left Ventricular Assist Device is the Best Treatment Method for Elderly Patients with Advanced Heart Failure
- 1 January 2024
- journal article
- research article
- Published by Bayt Publications in The Turkish Journal of Geriatrics
- Vol. 27 (4) , 390-397
Abstract
Introduction: In end stage heart failure, cardiac transplantation is the gold standart treatment. But advance age (>65 years old) is one of the relative contrindication for cardiac trasnplantation. So these patients were left to their faith out of medical treatment. Material and Methods: Between april 2012 to december 2023, 98 left ventricular assit device implantation patients were retrospectively analysed. Patients divided into two group according to their ages (>65; <65 years old). Group were compared according to preoperative, perioperative and postoperative parameters. Results: The demographic datas, preoperative cardiac parameters, perioperative datas, postoperative datas and complication were similar according to statistically analyses. Statistically, the only difference between the groups is the day on which device thrombosis developed. Conclusion: Although the number of patients on the heart transplant list increases day by day, the number of donors does not increase. For this reason, advanced age is considered a relative contraindication for heart transplantation in many clinics. For this reason, the elderly patient group is left helpless apart from medical treatment. This study showed that left ventricular assist device therapy is a good alternative to transplantation in the group of patients sentenced to medical treatment. Keywords: Heart-Assist Devices; Heart Transplantation; Heart Failure.Keywords
This publication has 22 references indexed in Scilit:
- The Society of Thoracic Surgeons Intermacs Database Annual Report: Evolving Indications, Outcomes, and Scientific PartnershipsThe Annals of Thoracic Surgery, 2019
- Risk factors, mortality, and timing of ischemic and hemorrhagic stroke with left ventricular assist devicesThe Journal of Heart and Lung Transplantation, 2017
- Seventh INTERMACS annual report: 15,000 patients and countingThe Journal of Heart and Lung Transplantation, 2015
- Adverse neurologic events in patients bridged with long-term mechanical circulatory support: A device-specific comparative analysisThe Journal of Heart and Lung Transplantation, 2015
- Stroke After Left Ventricular Assist Device Implantation: Outcomes in the Continuous-Flow EraThe Annals of Thoracic Surgery, 2015
- Predictors of hospital length of stay after implantation of a left ventricular assist device: An analysis of the INTERMACS registryThe Journal of Heart and Lung Transplantation, 2014
- Sixth INTERMACS annual report: A 10,000-patient databaseThe Journal of Heart and Lung Transplantation, 2014
- Results of the Post-U.S. Food and Drug Administration-Approval Study With a Continuous Flow Left Ventricular Assist Device as a Bridge to Heart TransplantationJACC, 2011
- Age and Outcome After Continuous-Flow Left Ventricular Assist Device Implantation as Bridge to TransplantationThe Journal of Heart and Lung Transplantation, 2009
- Left Ventricular Assist Device Performance With Long-Term Circulatory Support: Lessons From the REMATCH TrialThe Annals of Thoracic Surgery, 2004